ABBV-438
A Phase 1, First-in-Human, Open Label Study Evaluating Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ABBV-438 in Adult Subjects With Relapsed or Refractory Multiple Myeloma
Arms / Cohorts
Experimental:Part 2: ABBV-438 Monotherapy Dose Expansion (Dose B)
Not yet accepting
Experimental:Part 2: ABBV-438 Monotherapy Dose Expansion (Dose A)
Not yet accepting
Experimental:Part 1: ABBV-438 Monotherapy Dose Escalation
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.